Canada
Gemina Labs, founded in 2020 in Canada, is making waves in the Biotechnology, Data Analytics, Health Care, and Autonomous and Sensor Tech sectors. With a focus on developing a next-generation bio-sensing platform, this startup addresses a critical need: efficient, multi-pathogen detection.
Their proprietary chemistry platform is not only high-performing but also innovative. It significantly shortens prototype development times and breaks through traditional supply chain and accuracy challenges seen in diagnostics. This versatility opens doors to applications beyond infectious disease detection, venturing into personal well-being—a space ripe for quantitative insights into stress and fatigue monitoring.
While past investment details aren't available, Gemina Labs presents a compelling case for investors wanting to tap into a sector with room for expansive growth and transformative impact.
